Global ingredients distributor Azelis is strengthening its presence in the Indian food segment by acquiring the distribution activities of MK Ingredients & Specialties and SSD Industries (combined MK).

MK’s distribution activities include food applications such as confectionery, bakery and dairy, as well as its non-food segments comprising paints, coatings and chemicals for industrial markets.

The acquisition is in line with the Azelis’ corporate strategy of organic growth.

Azelis Asia Pacific president and CEO Laurent Nataf said: “MK and Azelis India have a solid and highly compatible supplier mix and this acquisition will help increase the value Azelis can bring to our customers and principals.

“It will provide us with an improved product offering and customer reach, in particular within the food industry. MK Ingredients won an award for best APAC distributor in 2016 and for exceptional business growth in 2018.

“We will benefit from Azelis’ speciality focus and connectivity with blue-chip principals on a global level.”

“This clearly demonstrates the great partnerships they have with principals, a value which is shared by Azelis.”

With this acquisition, Azelis intends to grow its food and health business, as well as improve product offerings and customer reach.

Additionally, Azelis will acquire MK’s food laboratory.

MK Ingredients managing partner Dipan Dalal said: “There is an excellent strategic fit and we are excited by the opportunity we now have for further growth in this market.

“We will benefit from Azelis’ speciality focus and connectivity with blue-chip principals on a global level, whilst the new setup will offer a much wider product portfolio and know-how to our customers.

“Furthermore, Azelis has a well-established operating platform and logistics expertise which will accelerate our service efficiency.”

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.

You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.